搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
9 小时
on MSN
Competition explodes amid weight loss drug shortage
Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...
10 小时
Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent set to advance in top drug sales
AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...
1 天
Here is What Jim Cramer Likes Pfizer Inc. (NYSE:PFE)
The CNBC host said that he has reminded his viewers repeatedly that when the Fed is your “enemy” you should stick to ...
1 天
Early Study Shows Weight Loss Pill Amycretin May Lead to Significant Results Compared to ...
The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...
1 天
on MSN
Here are the Medicare Part D drugs expected to face 2025 price negotiations
With prices finalized for the first 10 Medicare Part D drugs selected for the initial round of pricing negotiations, ...
1 天
15 Unhealthiest Countries in Europe
Here is our list of the 15 unhealthiest countries in Europe. Insider Monkey Score: 14.5 ...
Futurism
1 天
People Taking Semaglutide Appear to Be WAY Less Likely to Die of an Opioid Overdose
People who take Novo Nordisk's semaglutide-based injectables Ozempic and Wegovy seem to be way less likely to die from ...
1 天
Insider Today: Austin's genius housing fix
In this Saturday version of Insider Today, we're talking about Austin, Texas' real estate cycle and the price of weight-loss ...
Opinion
Kennebec Journal
1 天
Opinion
Commentary: Who’s really keeping Ozempic and Wegovy prices so high?
On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...
redstateobserver
1 天
Ozempic Lawsuits Spotlight Pharma's Dangerous Lack of Transparency
The controversy surrounding Ozempic, a popular diabetes medication turned weight-loss solution, has exploded as victims of severe side effects unite to file lawsuits against its manufacturers, Novo ...
Becker's Hospital Review
2 天
Why GLP-1s might treat a plethora of conditions
Discover the potential of GLP-1 medications like Ozempic and Mounjaro in treating a wide range of conditions, from diabetes to addiction.
2 天
Senator Bernie Sanders grills the top executive of Novo Nordisk over high drug prices
The Senate investigation showed Americans pay $1,349 a month for the weight-loss drug Wegovy, which is priced at $92 in the United Kingdom.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈